Polysomnography (PSG) is the standard test for diagnosing sleep apnea. However, the approach is obtrusive, time-consuming, and with limited access for patients in need of sleep apnea diagnosis. In recent years, there have been many attempts to search for an alternative device or approach that avoids the limitations of PSG. Pressure-sensitive mats (PSM) have proven to be able to detect central sleep apneas (CSA) and be a potential alternative for PSG. In the current study, we combine advanced machine learning approaches with a practical unobtrusive home monitoring device (PSM) to detect CSA events from data collected nocturnally and unattended. Two deep learning methods are implemented for the automatic detection of CSA events: a temporal convolutional network (TCN) and a bidirectional long short-term memory (BiLSTM) network. The deep learning models are compared to a classical machine learning approach (linear support vector machine, SVM) and a simple threshold-based algorithm. Considering the characteristics of each method, we choose strategies, including resampling and weighted cost-functions, to optimize the methods and to perform CSA detection as anomaly detection in an imbalanced data set. We evaluate the performance of all models on a database containing 7 days of data from 9 elderly patients. From the resulting 63 days, data from 7 patients (49 days) are devoted to training for optimizing hyperparameters, and data from 2 patients (14 days) are devoted to testing. Experimental results indicate that the bestperforming model achieves an accuracy of 95.1% through training an BiLSTM network. Overall, the implemented deep learning methods achieve better performance than the conventional classification approach (SVM) and the simple threshold-based method, and show good potential for the use of PSM for practical unobtrusive monitoring of CSA.
Accurate and efficient segmentation of live-cell images is critical in maximizing data extraction and knowledge generation from high-throughput biology experiments. Despite recent development of deep-learning tools for biomedical imaging applications, great demand for automated segmentation tools for high-resolution live-cell microscopy images remains in order to accelerate the analysis. YeastNet dramatically improves the performance of the non-trainable classic algorithm, and performs considerably better than the current state-of-the-art yeast-cell segmentation tools. We have designed and trained a U-Net convolutional network (named YeastNet) to conduct semantic segmentation on bright-field microscopy images and generate segmentation masks for cell labeling and tracking. YeastNet enables accurate automatic segmentation and tracking of yeast cells in biomedical applications. YeastNet is freely provided with model weights as a Python package on GitHub.
As the Coronavirus Disease 2019 (COVID-19) continues to impact many aspects of life and the global healthcare systems, the adoption of rapid and effective screening methods to prevent the further spread of the virus and lessen the burden on healthcare providers is a necessity. As a cheap and widely accessible medical image modality, point-of-care ultrasound (POCUS) imaging allows radiologists to identify symptoms and assess severity through visual inspection of the chest ultrasound images. Combined with the recent advancements in computer science, applications of deep learning techniques in medical image analysis have shown promising results, demonstrating that artificial intelligence-based solutions can accelerate the diagnosis of COVID-19 and lower the burden on healthcare professionals. However, the lack of large, well annotated datasets poses a challenge in developing effective deep neural networks, especially in the case of rare diseases and new pandemics. To address this issue, we present COVID-Net USPro, an explainable few-shot deep prototypical network that is designed to detect COVID-19 cases from very few ultrasound images. Through intensive quantitative and qualitative assessments, the network not only demonstrates high performance in identifying COVID-19 positive cases, using an explainability component, but it is also shown that the network makes decisions based on the actual representative patterns of the disease. Specifically, COVID-Net USPro achieves 99.55% overall accuracy, 99.93% recall, and 99.83% precision for COVID-19-positive cases when trained with only five shots. In addition to the quantitative performance assessment, our contributing clinician with extensive experience in POCUS interpretation verified the analytic pipeline and results, ensuring that the network’s decisions are based on clinically relevant image patterns integral to COVID-19 diagnosis. We believe that network explainability and clinical validation are integral components for the successful adoption of deep learning in the medical field. As part of the COVID-Net initiative, and to promote reproducibility and foster further innovation, the network is open-sourced and available to the public.